Log In
Sign Up
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
nature.com
Post by
|
1 points
|
Dec 2, 2023
|
Add Comment
About
FAQ
Legal
Contact
© 2023-24 DxMultiomics. All rights reserved.
